EPO906 Therapy in Patients With Prostate Cancer
NCT00035113
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Neoplasms
Interventions
DRUG:
epothilone b
Sponsor
Novartis Pharmaceuticals